H-1B sponsorship profile: QPharma, Inc. Across U.S. Department of Labor LCA disclosures, QPharma, Inc filed 21 Labor Condition Applications covering 21 H-1B worker positions between fiscal year 2023 and fiscal year 2025. The employer’s DOL certification rate sits at 90.5% (19 certified of 21 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on QPharma, Inc’s H-1B petitions range from $90,000 at the low end to $188,845 at the high end, with a petition-weighted average of $133,234. That range reflects the mix of occupations the company sponsors, led by Technical Product Owner, Validated Applications (6 petitions at $150,750 avg), followed by Senior Validation Engineer and Validation Engineer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. QPharma, Inc is headquartered in Morristown, NJ under NAICS code 325412, and places H-1B workers across 2 states, most heavily in NJ, PA. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where QPharma, Inc ranks. By H-1B petition volume, QPharma, Inc is #9,785 of 119,880 employers nationally and #917 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.